Alexion

("Alexion", or the "Company") reported net product sales of Soliris ® (eculizumab) of $156.0 million, reflecting strong additions of new patients, compared to $110.6 million for the same period in 2009.

unknown title 2011

Alexion Pharmaceuticals, Inc. ( "Alexion" or, the "Company") reported net product sales of Soliris

THE MEDICAL NEWS Editors 2010

("Alexion" or the "Company") reported total revenues of $141.6 million from net product sales of Soliris

Alexion Reports Third Quarter 2010 Results - Yahoo! Finance 2010

Dr. Penn's case appears to have been a fluke or clerical error, Mr. Hunsader of Nanex says, since there is no record of Alexion ever hitting $47 that day.

How Small Investors Can Get Stomped Jason Zweig 2011

Christophe Vorlet for The Wall Street Journal On May 21, 2010, just after the "flash crash" of May 6, Dr. Penn put a stop-loss on 400 shares of Alexion Pharmaceuticals at $47—an order to sell the shares if, but only if, they fell to that price.

How Small Investors Can Get Stomped Jason Zweig 2011

Alexion aims to build upon its success with its Soliris drug, which treats a rare disease in which blood cells break down earlier than normal, leading to numerous complications that can be fatal.

Alexion to Acquire Enobia Pharma for Up to $1.08 Billion Tess Stynes 2011

Alexion Pharmaceuticals Inc. agreed to acquire privately held Enobia Pharma Corp. in a deal valued at up to $1.08 billion, expanding Alexion's involvement with treatments for very rare life-threatening diseases.

Alexion to Acquire Enobia Pharma for Up to $1.08 Billion Tess Stynes 2011

In morning trading, shares of Alexion were retreating, pulling back about 1.1%.

Expedia Drops On Goldman Downgrade MarketNewsVideo.com 2011

Alexion, which on Wednesday affirmed its 2011 projections issued in October, said more details of the financial impact of the transaction will be included in its 2012 outlook, scheduled for release in February.

Alexion to Acquire Enobia Pharma for Up to $1.08 Billion Tess Stynes 2011

After a 2-for-1 split earlier this year, Alexion recently traded at $64; the shares Dr. Penn was forced to sell for just under $20,000 would be worth some $51,000 today.

How Small Investors Can Get Stomped Jason Zweig 2011